Literature DB >> 27663638

PET imaging approaches for inflammatory lung diseases: Current concepts and future directions.

Delphine L Chen1, Mark L Schiebler2, Jin Mo Goo3, Edwin J R van Beek4.   

Abstract

Inflammatory lung disease is one of the most common clinical scenarios, and yet, it is often poorly understood. Inflammatory lung disorders, such as chronic obstructive pulmonary diseases, which are causing significant mortality and morbidity, have limited therapeutic options. Recently, new treatments have become available for pulmonary fibrosis. This review article will describe the new insights that are starting to be gained from positron emission tomography (PET) methods, by targeting molecular processes using dedicated radiotracers. Ultimately, this should aid in deriving better pathophysiological classification of these disorders, which will ultimately result in better evaluation of novel therapies.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  (18)F-NOS; (18)Fluoro-fluciclatide; (18)Fluorodeoxyglucose; Asthma; COPD; Positron emission tomography; Pulmonary fibrosis

Mesh:

Substances:

Year:  2016        PMID: 27663638     DOI: 10.1016/j.ejrad.2016.09.014

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  11 in total

Review 1.  Frontiers in positron emission tomography imaging of the vulnerable atherosclerotic plaque.

Authors:  Mark G MacAskill; David E Newby; Adriana A S Tavares
Journal:  Cardiovasc Res       Date:  2019-12-01       Impact factor: 10.787

2.  Improved discrimination between benign and malignant LDCT screening-detected lung nodules with dynamic over static 18F-FDG PET as a function of injected dose.

Authors:  Qing Ye; Jing Wu; Yihuan Lu; Mika Naganawa; Jean-Dominique Gallezot; Tianyu Ma; Yaqiang Liu; Lynn Tanoue; Frank Detterbeck; Justin Blasberg; Ming-Kai Chen; Michael Casey; Richard E Carson; Chi Liu
Journal:  Phys Med Biol       Date:  2018-09-06       Impact factor: 3.609

Review 3.  Non-oncological applications of RGD-based single-photon emission tomography and positron emission tomography agents.

Authors:  Thomas Ebenhan; Janke Kleynhans; Jan Rijn Zeevaart; Jae Min Jeong; Mike Sathekge
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-09-12       Impact factor: 9.236

Review 4.  Imaging the Injured Lung: Mechanisms of Action and Clinical Use.

Authors:  Maurizio Cereda; Yi Xin; Alberto Goffi; Jacob Herrmann; David W Kaczka; Brian P Kavanagh; Gaetano Perchiazzi; Takeshi Yoshida; Rahim R Rizi
Journal:  Anesthesiology       Date:  2019-09       Impact factor: 7.892

Review 5.  Quantification of Lung PET Images: Challenges and Opportunities.

Authors:  Delphine L Chen; Joseph Cheriyan; Edwin R Chilvers; Gourab Choudhury; Christopher Coello; Martin Connell; Marie Fisk; Ashley M Groves; Roger N Gunn; Beverley F Holman; Brian F Hutton; Sarah Lee; William MacNee; Divya Mohan; David Parr; Deepak Subramanian; Ruth Tal-Singer; Kris Thielemans; Edwin J R van Beek; Laurence Vass; Jeremy W Wellen; Ian Wilkinson; Frederick J Wilson
Journal:  J Nucl Med       Date:  2017-01-12       Impact factor: 10.057

6.  The quantitative assessment of interstitial lung disease with positron emission tomography scanning in systemic sclerosis patients.

Authors:  Daphne M Peelen; Ben G J C Zwezerijnen; Esther J Nossent; Lilian J Meijboom; Otto S Hoekstra; Conny J Van der Laken; Alexandre E Voskuyl
Journal:  Rheumatology (Oxford)       Date:  2020-06-01       Impact factor: 7.580

7.  Inflammatory response in lungs and extrapulmonary sites detected by [18F] fluorodeoxyglucose PET/CT in convalescing COVID-19 patients tested negative for coronavirus.

Authors:  Yan Bai; Junling Xu; Lijuan Chen; Chang Fu; Georges Ei Fakhri; Jianqin Gu; Fengmin Shao; Meiyun Wang; Yi Kang; Weifeng Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-09       Impact factor: 9.236

8.  18F-FDG positron emission tomography scanning in systemic sclerosis-associated interstitial lung disease: a pilot study.

Authors:  Emmanuel Ledoult; Maxime Morelle; Clio Baillet; David Launay; Michael Soussan; Arsène Mékinian; Hélène Béhal; Vincent Sobanski; Eric Hachulla; Damien Huglo; Noémie Le Gouellec; Martine Remy-Jardin
Journal:  Arthritis Res Ther       Date:  2021-03-06       Impact factor: 5.156

9.  The lungs were on fire: a pilot study of 18F-FDG PET/CT in idiopathic-inflammatory-myopathy-related interstitial lung disease.

Authors:  Junyu Liang; Heng Cao; Yinuo Liu; Bingjue Ye; Yiduo Sun; Yini Ke; Ye He; Bei Xu; Jin Lin
Journal:  Arthritis Res Ther       Date:  2021-07-23       Impact factor: 5.156

Review 10.  Fibrosis imaging: Current concepts and future directions.

Authors:  Maike Baues; Anshuman Dasgupta; Josef Ehling; Jai Prakash; Peter Boor; Frank Tacke; Fabian Kiessling; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2017-11-20       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.